Institute of Tropical Medicine Antwerp
Foundation of Public Utility

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

DSpace/Manakin Repository

Files in this item

This item appears in the following Collection(s)